You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2025

Drugs in ATC Class N01BC


✉ Email this page to a colleague

« Back to Dashboard


Drugs in ATC Class: N01BC - Esters of benzoic acid

TradenameGeneric Name
GOPRELTO cocaine hydrochloride
NUMBRINO cocaine hydrochloride
>Tradename>Generic Name
Showing 1 to 2 of 2 entries

N01BC Market Analysis and Financial Projection

The ATC class N01BC (Esters of benzoic acid) primarily encompasses pharmaceutical-grade cocaine, which remains a niche but strategically important segment in medical applications. Here's an analysis of its market dynamics and patent landscape:


Market Dynamics

  1. Pharmaceutical Demand

    • Cocaine hydrochloride (N01BC01) is used in specialized medical settings, such as topical anesthesia for nasal surgeries[7][11]. The legal cocaine market is projected to grow at a 4% CAGR (2021–2025), driven by controlled medical applications[16].
    • Key vendors include Mallinckrodt, Merck, and Stepan Co., with North America dominating due to higher surgical volumes and regulatory frameworks[16][17].
  2. Regulatory Trends

    • Expansion is linked to decriminalization efforts in some regions and streamlined approval for pharmaceutical-grade cocaine[16]. However, strict international controls under the Single Convention on Narcotic Drugs limit broader market growth[13].
  3. Raw Material Trends

    • Benzoic acid esters (including cocaine) benefit indirectly from the broader benzoic acid market, which is growing at 3.26% CAGR (2024–2030) due to demand in food preservatives and pharmaceuticals[12].

Patent Landscape

Key Innovations and Protections

Patent Focus Description Key Players/Patents Expiry/Status
Synthesis Methods Electrochemical reduction of precursors for cocaine production[18] WO2019143508A1 (efficient synthesis of (-)-cocaine HCl)[18] Active
Formulations Nasal solutions for surgical anesthesia[7][11] GOPRELTO® (12 patents, including methods for nasal application)[11] Earliest generic: 2037
Addiction Treatment MEAI + N-Acylethanolamines for reducing cocaine cravings[15][19] Clearmind Medicine (KR patent 102025-0001, preclinical stage)[15][19] Pending trials

Competitive IP Activity

  • TSMC and Samsung lead in hybrid bonding patents (unrelated to N01BC but indicative of adjacent tech trends)[3][6].
  • Litigation Risks: 63% of patent challenges succeed, but GOPRELTO® faces limited competition due to controlled-substance regulations[11].

Growth Drivers vs. Challenges

Drivers:

  • Rising surgical volumes requiring localized anesthesia[17].
  • Innovations in addiction treatment (e.g., Clearmind’s targeted therapy)[19].

Challenges:

  • Stigma and regulatory barriers for cocaine-based products[13][16].
  • Dependency on opioid alternatives amid tightening drug policies[9].

Strategic Insights

  • White Spaces: Limited competition in pharmaceutical cocaine due to high regulatory hurdles[16].
  • Emerging Markets: Asia-Pacific shows potential with growing medical tourism and anesthesia demand[17].

"The legal cocaine market remains a high-barrier niche, but R&D into synthesis and addiction treatments may unlock long-term value." – Hybrid Bonding Patent Landscape Analysis 2024[6]

This sector balances ethical constraints with specialized medical needs, requiring nuanced IP and regulatory strategies.

References

  1. https://en.wikipedia.org/wiki/ATC_code_N01
  2. https://seekingalpha.com/article/4769387-national-bank-of-canada-might-not-be-undervalued
  3. https://www.knowmade.com/technology-news/semiconductor-news/semiconductor-packaging-news/advanced-semiconductor-packaging-leading-patent-owners-and-new-entrants/
  4. https://www.atccode.com/N01B
  5. https://atcddd.fhi.no/filearchive/publications/2025_guidelines__final_web.pdf
  6. https://www.knowmade.com/patent-analytics-services/patent-report/semiconductor-patent-landscape/semiconductor-advanced-packaging-patent-landscape/hybrid-bonding-patent-landscape-analysis-2024/
  7. https://atcddd.fhi.no/atc_ddd_index/?code=N01BC01
  8. https://portalcris.lsmuni.lt/server/api/core/bitstreams/d275648a-6f66-450b-b7d2-b833009c2026/content
  9. https://institute.global/insights/public-services/two-sides-same-coin-link-between-drug-markets-and-serious-violence
  10. https://caldwelllaw.com/news/how-patent-landscape-analysis-drives-business-growth/
  11. https://www.drugpatentwatch.com/p/tradename/GOPRELTO
  12. https://www.marketresearchfuture.com/reports/benzoic-acid-market/market-analysis
  13. https://www.unodc.org/documents/data-and-analysis/cocaine/Global_cocaine_report_2023.pdf
  14. https://www.ipcheckups.com/patent-landscape-analysis-overview/
  15. https://www.stocktitan.net/news/CMND/clearmind-medicine-announces-publication-of-patent-for-cocaine-lur31i7d5zey.html
  16. https://www.businesswire.com/news/home/20210721005430/en/Global-Legal-Cocaine-Market-Report-2021-2025---Growing-Demand-for-Pharmaceutical-grade-Cocaine-and-Rising-Number-of-Countries-Decriminalizing-and-Legalizing-Cocaine---ResearchAndMarkets.com
  17. https://straitsresearch.com/report/local-anesthesia-drugs-market
  18. https://patents.google.com/patent/WO2019143508A1/en
  19. https://www.nasdaq.com/articles/clearmind-medicine-inc-announces-patent-publication-innovative-combination-therapy-0

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.